Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 2,061.7%

Raia Drogasil S.A. (OTCMKTS:RADLYGet Free Report) was the recipient of a large increase in short interest in May. As of May 29th, there was short interest totaling 10,333 shares, an increase of 2,061.7% from the May 14th total of 478 shares. Based on an average daily trading volume, of 67,516 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Read Our Latest Report on Raia Drogasil

Raia Drogasil Stock Down 2.6%

RADLY traded down $0.09 on Tuesday, hitting $3.43. 7,083 shares of the company’s stock traded hands, compared to its average volume of 19,914. The company’s 50 day simple moving average is $4.24 and its 200-day simple moving average is $4.49. Raia Drogasil has a one year low of $2.21 and a one year high of $5.34.

Raia Drogasil Company Profile

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

Further Reading

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.